pharmtrace, founded in 2006, is a privately owned clinical CRO that has achieved the significant milestones of financial stability and a solid base of 15 core staff. Our forward order book covers our fixed operational costs for the next four years.

pharmtrace provides you with a single point access to a unique combination of medical imaging, diagnostics and drug development expertise. We know how to design the most appropriate clinical protocols to maximise the power of diagnostics and medical imaging in drug development programmes. We can also take care of imaging centre identification, evaluation, qualification, ongoing monitoring and quality control through to image collection, storage, statistical analysis and reporting.

Our development has been funded entirely by retained earning and an uncompromising focus on quality and continuous improvement. Our primary measure of success is the value of, the relevance of and the impact of our services on your success. Our business model is 100% focused on our clients’ needs and not on short-term financial returns. This allows us to concentrate on positioning ourselves to be, within five years, a market leader in the provision of high quality contract imaging services to the drug development industry.

We build long-term co-operations with our clients and partners based on mutual respect, the proactive identification of study needs and limitations, reliability, open and efficient communication and the professional delivery of quality data in the agreed timeframe. Our internal systems are designed to flexibly interface, whilst maintaining quality and data integrity, with those of our clients.